Clair Health raises $11.6M for noninvasive hormone monitor

Clair Health raised $11.6 million from Khosla Ventures for a noninvasive wearable hormone monitor that ships in November. The wristband uses 10 biosensors and AI to track estrogen, progesterone, LH, and FSH. The company reports 94% accuracy against urine samples but has no peer-reviewed results yet.